Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportMolecular Targeting Probes - Radioactive and Nonradioactive

Synthesis of a new bifunctional chelating agent for one step F-18 labeling and implementation in labeling of [F-18]AlF-NODA-RGD peptide for tumor angiogenesis imaging

Dinesh Shetty, Jae Jeong, Lathika Hoigebazar, Yun-Sang Lee, Dong Soo Lee, June-Key Chung, Myung Lee and Hyunsuk Shim
Journal of Nuclear Medicine May 2012, 53 (supplement 1) 1529;
Dinesh Shetty
1Nuclear Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jae Jeong
1Nuclear Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lathika Hoigebazar
1Nuclear Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yun-Sang Lee
1Nuclear Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dong Soo Lee
1Nuclear Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
June-Key Chung
1Nuclear Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Myung Lee
1Nuclear Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hyunsuk Shim
2Radiology, Emory University, Atlanta, GA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1529

Objectives For the general application of improved F-18 biomolecule labeling, we synthesized a bifunctional chelating agent containing isothiocyanate and NODA moieties for [F-18]AlF method.1 It can be conjugated onto a target molecule containing an amino functional group under mild basic conditions by formation of thiourea bond. We explored the application of synthesized agent by conjugating to a well-known αvβ3 integrin targeting peptide, c(RGDyK).

Methods Active ligand NODA-SCN was synthesized in four steps. Extended amino group of lysine in c(RGDyK) was conjugated with active ligand under basic condition (pH ~9). Conjugated product (NODA-SCN-RGD) was purified by prep-HPLC. Ligand conjugated peptide was labeled with freshly prepared [F-18](AlF)2+. Labeling efficiency was tested using ITLC. Biodistribution of [F-18]AlF-NODA-SCN-RGD was studied in nude balb/c mice bearing glioma xenografts at 60 min. Small animal PET images were obtained after 1 and 2 hr post-injection of the labeled agent.

Results NODA-SCN was synthesized with overall good yield (>50%). The conjugated peptide showed good radiochemical yield and efficiency with an excellent radiochemical purity (97.1±1.2%) in a short reaction time (10 min). Labeled peptide showed excellent in vitro and in vivo stability (>95%). αvβ3 integrin specific tumor uptake was observed both in biodistribution (4.41 ± 0.98 %ID/g at 60 min p.i) and small animal microPET (SUV of 7.42 ± 0.49) studies. These values reduced significantly in the blocking study with co-injection of cold c(RGD)yK (3 mg/kg), which shows the specificity of labeled peptide.

Conclusions We developed a bifunctional chelating agent NODA-SCN for labeling peptides with F-18 using an AlF method. Successful application of the agent for F-18 labeling of RGD peptide demonstrated the feasibility of this ligand as a general protein and peptide labeling agent.

Research Support This research was partly supported by the Converging Research Center Program (2010K001055) and National Research Laboratory Program (R0A-2008-000-20116-0) through the Ministry of Education, Sciences and Technology

Back to top

In this issue

Journal of Nuclear Medicine
Vol. 53, Issue supplement 1
May 2012
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Synthesis of a new bifunctional chelating agent for one step F-18 labeling and implementation in labeling of [F-18]AlF-NODA-RGD peptide for tumor angiogenesis imaging
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Synthesis of a new bifunctional chelating agent for one step F-18 labeling and implementation in labeling of [F-18]AlF-NODA-RGD peptide for tumor angiogenesis imaging
Dinesh Shetty, Jae Jeong, Lathika Hoigebazar, Yun-Sang Lee, Dong Soo Lee, June-Key Chung, Myung Lee, Hyunsuk Shim
Journal of Nuclear Medicine May 2012, 53 (supplement 1) 1529;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Synthesis of a new bifunctional chelating agent for one step F-18 labeling and implementation in labeling of [F-18]AlF-NODA-RGD peptide for tumor angiogenesis imaging
Dinesh Shetty, Jae Jeong, Lathika Hoigebazar, Yun-Sang Lee, Dong Soo Lee, June-Key Chung, Myung Lee, Hyunsuk Shim
Journal of Nuclear Medicine May 2012, 53 (supplement 1) 1529;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Molecular Targeting Probes - Radioactive and Nonradioactive

  • Comparison of a new 18F renal tracer, Al18F-NODA-butyric acid, with 131I-OIH in normal rats
  • Synthesis of N4amG as a novel probe for cell nucleus activity assessment
  • Quantitative determination of 68Ge breakthrough of 68Ge/68Ga generators via TLC
Show more Molecular Targeting Probes - Radioactive and Nonradioactive

Special MTA: Novel Radioactive Probes Posters

  • Synthesis of 68Ga-NOTA-UBI30-41 and in vivo biodistribution in vervet monkeys towards potential PET/CT imaging of infection
  • Influence of 99mTc-labeling strategies in physicochemical and biological properties of a biologically active ligand
  • Development of [18F]BMS-754807 as a potential PET tracer for the insulin-like growth factor-1 receptor (IGF-1R)
Show more Special MTA: Novel Radioactive Probes Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire